Bloom Tree Partners’s Insys Therapeutics, Inc. INSY Stock Holding History

Bloom Tree Partners’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-704,006	Closed	-$25.3M	–	35
2015 Q2	$25.3M	Buy	+704,006	New	+$21.9M	2.29%	22
2014 Q4	–	Sell	-1,070,000	Closed	-$20.7M	–	39
2014 Q3	$20.7M	Sell	1,070,000 -500,000	-32%	-$7.85M	2.72%	19
2014 Q2	$24.5M	Buy	+1,570,000	New	+$25.4M	2.87%	19

Other funds holding INSY

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bloom Tree Partners's INSY Position: Q3 2015 in Review

Bloom Tree Partners sold out of Insys Therapeutics, Inc. (INSY) in Q3 2015, closing a stake of 704,006 shares — an estimated $25.3M sold.

Bloom Tree Partners first reported a position in INSY in Q2 2014 and held it in 3 quarters. The position peaked at $25.3M in Q2 2015. 145 funds tracked by Wall St. Rank hold INSY as of Q3 2015.

Bloom Tree Partners reported no remaining Insys Therapeutics, Inc. position as of Q3 2015 after selling out during the quarter.
Bloom Tree Partners sold 704,006 Insys Therapeutics, Inc. shares in Q3 2015, an estimated $25.3M.
Bloom Tree Partners first reported a position in Insys Therapeutics, Inc. in Q2 2014 and held it in 3 quarters.
Bloom Tree Partners's Insys Therapeutics, Inc. position peaked at $25.3M in Q2 2015.
145 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2015.

Based on Bloom Tree Partners's 13F filing for Q3 2015, filed 16 Nov 2015.